Aquestive Therapeutics (AQST) Competitors $2.57 +0.05 (+1.98%) Closing price 04:00 PM EasternExtended Trading$2.54 -0.03 (-1.36%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AQST vs. BGM, OCUL, IOVA, SNDX, WVE, COLL, ELVN, DYN, GPCR, and ETNBShould you be buying Aquestive Therapeutics stock or one of its competitors? The main competitors of Aquestive Therapeutics include Qilian International Holding Group (BGM), Ocular Therapeutix (OCUL), Iovance Biotherapeutics (IOVA), Syndax Pharmaceuticals (SNDX), Wave Life Sciences (WVE), Collegium Pharmaceutical (COLL), Enliven Therapeutics (ELVN), Dyne Therapeutics (DYN), Structure Therapeutics (GPCR), and 89bio (ETNB). These companies are all part of the "pharmaceutical products" industry. Aquestive Therapeutics vs. Qilian International Holding Group Ocular Therapeutix Iovance Biotherapeutics Syndax Pharmaceuticals Wave Life Sciences Collegium Pharmaceutical Enliven Therapeutics Dyne Therapeutics Structure Therapeutics 89bio Aquestive Therapeutics (NASDAQ:AQST) and Qilian International Holding Group (NASDAQ:BGM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, community ranking, dividends, risk and analyst recommendations. Is AQST or BGM more profitable? Qilian International Holding Group has a net margin of 0.00% compared to Aquestive Therapeutics' net margin of -59.75%. Company Net Margins Return on Equity Return on Assets Aquestive Therapeutics-59.75% N/A -33.96% Qilian International Holding Group N/A N/A N/A Which has more volatility and risk, AQST or BGM? Aquestive Therapeutics has a beta of 2.59, indicating that its stock price is 159% more volatile than the S&P 500. Comparatively, Qilian International Holding Group has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Does the media prefer AQST or BGM? In the previous week, Aquestive Therapeutics had 4 more articles in the media than Qilian International Holding Group. MarketBeat recorded 5 mentions for Aquestive Therapeutics and 1 mentions for Qilian International Holding Group. Qilian International Holding Group's average media sentiment score of 1.87 beat Aquestive Therapeutics' score of 1.36 indicating that Qilian International Holding Group is being referred to more favorably in the news media. Company Overall Sentiment Aquestive Therapeutics Positive Qilian International Holding Group Very Positive Which has preferable earnings & valuation, AQST or BGM? Qilian International Holding Group has lower revenue, but higher earnings than Aquestive Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAquestive Therapeutics$57.56M4.41-$7.87M-$0.52-4.94Qilian International Holding Group$25.10M40.64-$1.44MN/AN/A Do analysts rate AQST or BGM? Aquestive Therapeutics currently has a consensus price target of $10.67, indicating a potential upside of 315.05%. Given Aquestive Therapeutics' stronger consensus rating and higher probable upside, research analysts plainly believe Aquestive Therapeutics is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aquestive Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer AQST or BGM? Aquestive Therapeutics received 216 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformAquestive TherapeuticsOutperform Votes21668.35% Underperform Votes10031.65% Qilian International Holding GroupN/AN/A Do institutionals and insiders hold more shares of AQST or BGM? 32.5% of Aquestive Therapeutics shares are owned by institutional investors. 7.9% of Aquestive Therapeutics shares are owned by insiders. Comparatively, 58.7% of Qilian International Holding Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryAquestive Therapeutics beats Qilian International Holding Group on 9 of the 15 factors compared between the two stocks. Remove Ads Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AQST vs. The Competition Export to ExcelMetricAquestive TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$254.10M$6.32B$5.33B$7.57BDividend YieldN/A3.23%5.11%4.32%P/E Ratio-5.716.7921.7317.81Price / Sales4.41225.96379.2094.61Price / CashN/A65.6738.1534.64Price / Book-1.625.866.464.00Net Income-$7.87M$141.86M$3.20B$247.23M7 Day Performance8.44%8.98%6.54%7.26%1 Month Performance-9.51%-12.65%-8.55%-6.26%1 Year Performance-34.77%-11.99%10.33%-0.18% Aquestive Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AQSTAquestive Therapeutics1.8952 of 5 stars$2.57+2.0%$10.67+315.0%-35.5%$254.10M$57.56M-5.71160Gap DownBGMQilian International Holding GroupN/A$10.62-0.9%N/AN/A$1.03B$25.10M0.00298Positive NewsOCULOcular Therapeutix3.4204 of 5 stars$6.30-0.9%$16.38+159.9%-5.3%$1.00B$63.72M-4.77230IOVAIovance Biotherapeutics4.2358 of 5 stars$3.03+1.0%$20.25+568.3%-72.4%$993.47M$164.07M-2.03500Analyst ForecastNews CoverageHigh Trading VolumeSNDXSyndax Pharmaceuticals3.4858 of 5 stars$10.99-2.3%$36.20+229.3%-48.3%$945.88M$23.68M-3.03110Gap DownWVEWave Life Sciences4.1775 of 5 stars$5.80-3.8%$22.60+289.7%+3.4%$890.22M$108.30M-5.23240Short Interest ↑Analyst RevisionCOLLCollegium Pharmaceutical4.0797 of 5 stars$27.38-2.7%$43.60+59.2%-25.1%$879.77M$631.45M11.80210News CoverageELVNEnliven Therapeutics2.5632 of 5 stars$17.82-4.7%$38.75+117.5%-18.5%$873.06MN/A-9.3850News CoverageDYNDyne Therapeutics3.73 of 5 stars$7.48-9.6%$47.46+534.3%-71.1%$846.37MN/A-2.10100Positive NewsGPCRStructure Therapeutics2.5757 of 5 stars$14.31-5.4%$81.29+468.0%-51.8%$820.58MN/A-19.34136News CoverageETNB89bio2.5885 of 5 stars$5.49-4.9%$27.56+401.9%-39.7%$801.45MN/A-1.8940Short Interest ↑News CoverageHigh Trading Volume Remove Ads Related Companies and Tools Related Companies BGM Alternatives OCUL Alternatives IOVA Alternatives SNDX Alternatives WVE Alternatives COLL Alternatives ELVN Alternatives DYN Alternatives GPCR Alternatives ETNB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AQST) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aquestive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AQST Stock Free AQST Stock Alerts